default author photo

Duygu Kuzuoglu-Ozturk

University of California, San Francisco (UCSF) - Department of Urology

San Francisco, CA 94143

United States

SCHOLARLY PAPERS

2

DOWNLOADS

147

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

AR Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Number of pages: 28 Posted: 30 Mar 2023
University of California, San Francisco (UCSF), Oregon Health and Science University - Knight Cancer Institute, Oregon Health and Science University - Department of Cell, Developmental and Cancer Biology, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), Oregon Health and Science University - Knight Cancer Institute, Oregon Health and Science University - Knight Cancer Institute, University of California, San Francisco (UCSF), Netherlands Cancer Institute - Division of Oncogenomics, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF) - Department of Urology, University of California, San Francisco (UCSF), Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Netherlands Cancer Institute - Division of Oncogenomics, University of California, San Francisco (UCSF) - Department of Urology, Columbia University, Center for Cancer Research, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), Netherlands Cancer Institute - Division of Oncogenomics, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), Oregon Health and Science University - Knight Cancer Institute and University of California, San Francisco (UCSF)
Downloads 93 (725,554)

Abstract:

Loading...

prostate cancer, major histocompatibility complex class I, androgen receptor, antigen presentation, immune response

2.

Revealing New Molecular Pathways for Cancer Cell Fitness Through a Genetic Screen of the Cancer Translatome

Number of pages: 53 Posted: 27 Oct 2020
University of California, San Francisco (UCSF) - Department of Urology, University of California, Berkeley - Department of Plant and Microbial Biology, University of California, San Francisco (UCSF) - Department of Urology, University of California, San Francisco (UCSF) - Department of Urology, University of California, San Francisco (UCSF) - Department of Urology, eFFECTOR Therapeutics, eFFECTOR Therapeutics, University of California, Berkeley - Department of Plant and Microbial Biology, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Department of Urology and University of California, San Francisco (UCSF) - Department of Urology
Downloads 54 (1,020,567)

Abstract:

Loading...

cancer, eIF4E, translation control, autophagy, CRISPRi, Bcl-xL, Pmpcb, EJC, Tfeb, mitochondrial UPR